U.S. federal trademark · Serial No. 79422222 · Reg. No. 8090756
Pharmaceutical and biological preparations for the treatment of cancer and non-cancer fibrotic and inflammatory diseases for medical purposes; monoclonal antibodies for medical use; pharmaceutical preparations for the prevention, diagnosis and treatment of cancer and immune-mediated inflammatory and autoimmune diseases, namely tenosynovial giant cell tumor (TGCT), graft-versus-host disease, acute myeloid leukemia, chronic myelomonocytic leukemia, soft-tissue sarcoma, ovarian cancer, triple-negative breast cancer, head and neck cancer, malignant meningioma, T-cell lymphoma, osteosarcoma, glioblastoma, follicular lymphoma and malignant pleural mesothelioma; diagnostic reagents for medical purposes for use in connection with tenosynovial giant cell tumor (TGCT), graft-versus-host disease, acute myeloid leukemia, chronic myelomonocytic leukemia, soft tissue sarcoma, ovarian cancer, triple-negative breast cancer, head and neck cancer, malignant meningioma, T-cell lymphoma, osteosarcoma, glioblastoma, follicular lymphoma and malignant pleural mesothelioma
Scientific and medical research; pharmaceutical research and development; drug discovery services; pharmaceutical product development; testing of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; clinical scientific research in the fields of oncology and immunology; providing medical and scientific research information in the fields of oncology and immunology; design and development of pharmaceutical preparations and medicines
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.